IL1B and cancer: Since the above mentioned studies underlined that IL-1β directly or through specific molecular mechanisms impacts on tumor aggressiveness and bone metastatic potential, several studies hypothesized that the blocking of IL-1β activity should have the potential to be an effective anti-cancer therapy.